Last updated on October 2017

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients


Brief description of study

The study is a multicenter, open label Phase I/II trial. 1. Establish the MTD of fractionated doses of Lintuzumab-Ac225 in combination with low dose cytosine arabinoside (Low Dose Ara-C, LDAC) (Phase 1 portion) 2. Determine the response rate (CR + CRp + CRi) to fractionated doses of Lintuzumab-Ac225 alone (Phase 2 portion)

Clinical Study Identifier: NCT02575963

Contact Investigators or Research Sites near you

Start Over

Actinium Pharmaceuticals,Inc (Director of Clinical ...

UCLA Medical Center, Division of Hematology/Oncology
Los Angeles, CA United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

University of Kentucky, Markey Cancer Center
Lexington, KY United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

University of Louisville, James Graham Brown Cancer Center
Louisville, KY United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Ochsner Medical Center, The Gayle and Tom Benson Cancer Center
New Orleans, LA United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Weill Medical College of Cornell University
New York, NY United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Columbia University Medical, Herbert Irving Comprehensive Cancer Center
New York, NY United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Duke Cancer Center
Durham, NC United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

University of Pennsylvania, Perelman Center for Advanced Medicine
Philadelphia, PA United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

St. Francis Cancer Center
Greenville, SC United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Baylor Scott and White Research Institute, Charles A. Sammons Cancer Center
Dallas, TX United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Swedish Cancer Institute, Center for Blood Disorders and Stem Cell Transplantation
Seattle, WA United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Fred Hutchinson Cancer Research Center
Seattle, WA United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

West Virginia University, Mary Babb Randolph Cancer Center
Morgantown, WV United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

Medical College of Wisconsin Cancer Center
Milwaukee, WI United States
  Connect »

Actinium Pharmaceuticals,Inc (Director of Clinical ...

VA Caribbean Healthcare System
San Juan, Puerto Rico
  Connect »